Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-26-043782
Filing Date
2026-04-15
Accepted
2026-04-15 16:03:09
Documents
107
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kala-20251231x10k.htm   iXBRL 10-K 3657280
2 EX-4.3 kala-20251231xex4d3.htm EX-4.3 34708
3 EX-10.48 kala-20251231xex10d48.htm EX-10.48 105426
4 EX-10.49 kala-20251231xex10d49.htm EX-10.49 91412
5 EX-23.1 kala-20251231xex23d1.htm EX-23.1 5253
6 EX-23.2 kala-20251231xex23d2.htm EX-23.2 2526
7 EX-31.1 kala-20251231xex31d1.htm EX-31.1 8918
8 EX-31.2 kala-20251231xex31d2.htm EX-31.2 8872
9 EX-32.1 kala-20251231xex32d1.htm EX-32.1 5161
10 EX-32.2 kala-20251231xex32d2.htm EX-32.2 6784
11 GRAPHIC kala-20251231x10k006.jpg GRAPHIC 65834
12 GRAPHIC kala-20251231x10k007.jpg GRAPHIC 35606
13 GRAPHIC kala-20251231x10k008.jpg GRAPHIC 20097
14 GRAPHIC kala-20251231x10k009.jpg GRAPHIC 45242
15 GRAPHIC kala-20251231x10k010.jpg GRAPHIC 28954
16 GRAPHIC kala-20251231x10k011.jpg GRAPHIC 44551
  Complete submission text file 0001104659-26-043782.txt   13140746

Data Files

Seq Description Document Type Size
17 EX-101.SCH kala-20251231.xsd EX-101.SCH 85034
18 EX-101.CAL kala-20251231_cal.xml EX-101.CAL 68149
19 EX-101.DEF kala-20251231_def.xml EX-101.DEF 372325
20 EX-101.LAB kala-20251231_lab.xml EX-101.LAB 741333
21 EX-101.PRE kala-20251231_pre.xml EX-101.PRE 562893
111 EXTRACTED XBRL INSTANCE DOCUMENT kala-20251231x10k_htm.xml XML 1731611
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38150 | Film No.: 26864130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)